Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Liyang Pharmaceutical Development is a specialized pharmaceutical research and development enterprise based in Chongqing, China. Established in 2003, the company focuses on the technical development, transfer, and consultation of chemical drugs, traditional Chinese medicines, and biological products. It provides comprehensive contract research organization (CRO) services, including drug synthesis, formulation development, and quality control, with a particular emphasis on generic drug consistency evaluation. The company supports pharmaceutical manufacturers in optimizing production processes and achieving regulatory approvals for a variety of therapeutic agents, particularly in the cardiovascular space. Liyang Pharmaceutical is recognized as a high-tech enterprise and maintains a strong focus on intellectual property and technical innovation in drug manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Liyang Pharmaceutical Development.